Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 751672, 9 pages
http://dx.doi.org/10.1155/2015/751672
Research Article

Downregulation of miR-221 Inhibits Cell Migration and Invasion through Targeting Methyl-CpG Binding Domain Protein 2 in Human Oral Squamous Cell Carcinoma Cells

1The Medical Centre of Stomatology, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China
2Department of Oral & Maxillofacial Surgery, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China
3Department of Stomatology, Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510655, China
4Department of Oral & Maxillofacial Surgery, Guanghua School of Stomatology, Guangdong Provincial Key Laboratory of Stomatology, Sun Yat-Sen University, Guangzhou 510055, China

Received 28 August 2015; Accepted 30 November 2015

Academic Editor: Fumio Imazeki

Copyright © 2015 Shuqi He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Yu, Y. Wu, J. I. Helman, Y. Wen, C. Wang, and L. Li, “CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway,” Molecular Cancer Research, vol. 9, no. 2, pp. 161–172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Choi and J. N. Myers, “Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy,” Journal of Dental Research, vol. 87, no. 1, pp. 14–32, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Zini, R. Czerninski, and H. D. Sgan-Cohen, “Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites,” Journal of Oral Pathology and Medicine, vol. 39, no. 4, pp. 299–305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. F. C. A. de Aguiar Júnior, L. P. Kowalski, and O. P. de Almeida, “Clinicopathological and immunohistochemical evaluation of oral squamous cell carcinoma in patients with early local recurrence,” Oral Oncology, vol. 43, no. 6, pp. 593–601, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Ambros, “The functions of animal microRNAs,” Nature, vol. 431, no. 7006, pp. 350–355, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Liz and M. Esteller, “lncRNAs and microRNAs with a role in cancer development,” Biochimica et Biophysica Acta (BBA)—Gene Regulatory Mechanisms, 2015. View at Publisher · View at Google Scholar
  8. W. Wang, E. Zhang, and C. Lin, “MicroRNAs in tumor angiogenesis,” Life Sciences, vol. 136, pp. 28–35, 2015. View at Publisher · View at Google Scholar
  9. Z. Liu, Y. Xu, J. Long, K. Guo, C. Ge, and R. Du, “MicroRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1,” Chinese Journal of Cancer Research, vol. 27, no. 3, pp. 247–257, 2015. View at Google Scholar
  10. K. Tian, R. Di, and L. Wang, “MicroRNA-23a enhances migration and invasion through PTEN in osteosarcoma,” Cancer Gene Therapy, vol. 22, pp. 351–359, 2015. View at Publisher · View at Google Scholar
  11. M. Garofalo, C. Quintavalle, G. Romano, C. M. Croce, and G. Condorelli, “miR221/222 in cancer: their role in tumor progression and response to therapy,” Current Molecular Medicine, vol. 12, no. 1, pp. 27–33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Yang, W. Wang, C. Zhou et al., “miR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2,” Tumor Biology, vol. 36, no. 5, pp. 3763–3773, 2015. View at Publisher · View at Google Scholar
  13. K. Cai, F. Shen, J. H. Cui, Y. Yu, and H. Q. Pan, “Expression of miR-221 in colon cancer correlates with prognosis,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 2, pp. 2794–2798, 2015. View at Google Scholar
  14. H. W. Khella, H. Butz, Q. Ding et al., “miR-221/222 are involved in response to sunitinib treatment in metastatic renal cell carcinoma,” Molecular Therapy, vol. 23, no. 11, pp. 1748–1758, 2015. View at Publisher · View at Google Scholar
  15. C.-J. Yang, W. G. Shen, C.-J. Liu et al., “miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells,” Journal of Oral Pathology and Medicine, vol. 40, no. 7, pp. 560–566, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Nakayama, A. Sasaki, H. Mese, R. E. Alcalde, and T. Matsumura, “Establishment of high and low metastasis cell lines derived from a human tongue squamous cell carcinoma,” Invasion and Metastasis, vol. 18, no. 5-6, pp. 219–228, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Gioanni, J.-L. Fischel, J.-C. Lambert et al., “Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment,” European Journal of Cancer and Clinical Oncology, vol. 24, no. 9, pp. 1445–1455, 1988. View at Publisher · View at Google Scholar · View at Scopus
  18. R. He, Q. Xu, X. Zhou et al., “The establisment and some bilogical characteristics of a squamous cell line of the human tongue Tca8113,” Tumor, vol. 3, no. 3, pp. 97–100, 1983 (Chinese). View at Google Scholar
  19. E. A. Orellana and A. L. Kasinski, “MicroRNAs in cancer: a historical perspective on the path from discovery to therapy,” Cancers, vol. 7, no. 3, pp. 1388–1405, 2015. View at Publisher · View at Google Scholar
  20. L. Ma, J. Teruya-Feldstein, and R. A. Weinberg, “Tumour invasion and metastasis initiated by microRNA-10b in breast cancer,” Nature, vol. 449, no. 7163, pp. 682–688, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. S. F. Tavazoie, C. Alarcón, T. Oskarsson et al., “Endogenous human microRNAs that suppress breast cancer metastasis,” Nature, vol. 451, no. 7175, pp. 147–152, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Yang, Y. Yang, R. Gan et al., “Down-regulation of miR-221 and miR-222 restrain prostate cancer cell proliferation and migration that is partly mediated by activation of SIRT1,” PLoS ONE, vol. 9, no. 6, Article ID e98833, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. G. J. Lu, Y. Q. Dong, Q. M. Zhang et al., “miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 5, pp. 5224–5229, 2015. View at Google Scholar
  24. G. Cai, S. Qiao, and K. Chen, “Suppression of miR-221 inhibits glioma cells proliferation and invasion via targeting SEMA3B,” Biological Research, vol. 48, no. 1, pp. 15–30, 2015. View at Publisher · View at Google Scholar
  25. L. He and G. J. Hannon, “MicroRNAs: small RNAs with a big role in gene regulation,” Nature Reviews Genetics, vol. 5, no. 7, pp. 522–531, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. M. A. Valencia-Sanchez, J. Liu, G. J. Hannon, and R. Parker, “Control of translation and mRNA degradation by miRNAs and siRNAs,” Genes & Development, vol. 20, no. 5, pp. 515–524, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Winter, S. Jung, S. Keller, R. I. Gregory, and S. Diederichs, “Many roads to maturity: microRNA biogenesis pathways and their regulation,” Nature Cell Biology, vol. 11, no. 3, pp. 228–234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Cheishvili, F. Chik, C. C. Li et al., “Synergistic effects of combined DNA methyltransferase inhibition and MBD2 depletion on breast cancer cells; MBD2 depletion blocks 5-aza-2'-deoxycytidine-triggered invasiveness,” Carcinogenesis, vol. 35, no. 11, pp. 2436–2446, 2014. View at Publisher · View at Google Scholar
  29. L. Mei and W.-C. Xiong, “FAK interaction with MBD2: a link from cell adhesion to nuclear chromatin remodeling?” Cell Adhesion and Migration, vol. 4, no. 1, pp. 77–80, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. T. B. Pontes, E. S. Chen, C. O. Gigek et al., “Reduced mRNA expression levels of MBD2 and MBD3 in gastric carcinogenesis,” Tumor Biology, vol. 35, no. 4, pp. 3447–3453, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Stefanska, J. Huang, B. Bhattacharyya et al., “Definition of the landscape of promoter DNA hypomethylation in liver cancer,” Cancer Research, vol. 71, no. 17, pp. 5891–5903, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Shukeir, P. Pakneshan, G. Chen, M. Szyf, and S. A. Rabbani, “Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo,” Cancer Research, vol. 66, no. 18, pp. 9202–9210, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Pakneshan, B. Têtu, and S. A. Rabbani, “Demethylation of urokinase promoter as a prognostic marker in patients with breast carcinoma,” Clinical Cancer Research, vol. 10, no. 9, pp. 3035–3041, 2004. View at Publisher · View at Google Scholar · View at Scopus